960389-39-3

Basic information

• Product Name: (4S)-8-(3-bromophenyl)-8-(4-methoxyphenyl)-6-thioxo-2,3,4,6,7,8-hexahydroimidazo[1,5-a]pyrimidine-4-carboxylic acid
• Synonyms: (4S)-8-(3-bromophenyl)-8-(4-methoxyphenyl)-6-thioxo-2,3,4,6,7,8-hexahydroimidazo[1,5-a]pyrimidine-4-carboxylic acid
• CAS NO: 960389-39-3
• Molecular Weight: 460.351
• Mol File: 960389-39-3.mol

Chemical Properties

• CAS DataBase Reference: (4S)-8-(3-bromophenyl)-8-(4-methoxyphenyl)-6-thioxo-2,3,4,6,7,8-hexahydroimidazo[1,5-a]pyrimidine-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (4S)-8-(3-bromophenyl)-8-(4-methoxyphenyl)-6-thioxo-2,3,4,6,7,8-hexahydroimidazo[1,5-a]pyrimidine-4-carboxylic acid(960389-39-3)
• EPA Substance Registry System: (4S)-8-(3-bromophenyl)-8-(4-methoxyphenyl)-6-thioxo-2,3,4,6,7,8-hexahydroimidazo[1,5-a]pyrimidine-4-carboxylic acid(960389-39-3)

Safety Data

• Hazardous Substances Data: 960389-39-3(Hazardous Substances Data)

Upstream product

• 960388-66-3 4-[(3-Bromophenyl)(isothiocyanato)methyl]pyridine 
• 960388-62-9 1-(3-bromophenyl)-1-pyridin-4-ylmethanamine 
• 623-00-7 4-bromobenzenecarbonitrile 
• 960388-68-5 4-(3-bromophenyl)-4-(4-methoxyphenyl)-1,3-thiazolidine-2,5-dithione 
• 960388-64-1 1-bromo-3-[isothiocyanato(4-methoxyphenyl)methyl]benzene 
• 960388-60-7 (3-bromophenyl)(4-methoxyphenyl)methylamine 
• 10270-94-7 4--L-2,4-diaminobutyric acid 

Relevant articles and documents

AMINO- IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT. ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA.

This invention relates to novel compounds having the structural formula I below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.

AMINO-IMIDAZOLONES AND THEIR USE AS A MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT, ALZHEIMER DISEASE, NEURODEGENERATION AND DEMENTIA

This invention relates to novel compounds having the structural formula (I) and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.